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We examined the impact of Sindbis virus (SINV) infection on cell cycle progression in a cancer cell line,
HeLa, and a non-cancerous cell line, Vero. Cell cycle analyses showed that SINV infection is able to alter
the cell cycle progression in both HeLa and Vero cells, but differently, especially during the early stage of
infection. SINV infection affected the expression of several cell cycle regulators (CDK4, CDK6, cyclin E,
p21, cyclin A and cyclin B) in HeLa cells and caused HeLa cells to accumulate in S phase during the early
stage of infection. Monitoring SINV replication in HeLa and Vero cells expressing cell cycle indicators
revealed that SINV which infected HeLa cells during G1 phase preferred to proliferate during S/G2 phase,
and the average time interval for viral replication was signiﬁcantly shorter in both HeLa and Vero cells
infected during G1 phase than in cells infected during S/G2 phase.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Sindbis virus (SINV) is an RNA virus belonging to the Alphavirus
genus in the Togaviridae virus family. SINV is transmitted to birds
and mammals by mosquito bites and subsequently spreads
throughout the body through the bloodstream [1]. SINV infection
induces no or only mild symptoms (fever, rash, and arthralgia) in
humans [2]. SINV has the potential to induce apoptosis in infected
mammalian cells, but establishes a non-cytolytic persistent infec-
tion in arthropod cells [2,3]. In addition, the 67-kDa, high-afﬁnity
laminin receptor has been identiﬁed as a surface attachment fac-
tor that mediates SINV infection of mammalian cells [4], and is
highly expressed in various human cancers [5,6].
We reported previously that SINV has oncolytic features and
demonstrates antitumoral effects in various cancers, including
cervical and ovarian cancer [7], and human oral squamous carci-
noma cells [8]. Replication-defective SINV vectors have also been
developed to target and eradicate tumors [9,10].
As an oncolytic virus, the favorable features of SINV include
rapid production of high-titer virus, efﬁcient infection of a variety
of cancer cells, and a high RNA replication rate in the cytoplasm
[11]. The preferable characteristics of SINV for cancer therapy
might be attributed to the combination of favorable viral growth
and the uncontrolled cell proliferation of cancer cells, includingirasawa).
r Inc. This is an open access articlderegulation of the cell cycle. In normal cells, cell cycle regulator
proteins, cyclin-dependent protein kinases (CDKs), cyclins, and
CDK inhibitory proteins regulate progression through G1, S, G2 and
M phases in the cell cycle. Controls by these regulators are often
disturbed in cancer cells, which tend to remain in cycle [12]. Many
viruses can affect the cell cycle progression of host cells to favor
viral replication. Regarding DNA viruses, such as simian virus 40,
adenovirus, and papillomavirus, infected cells are promoted into S
phase (reviewed by Ref. [13]). Several RNA viruses also reportedly
affect the cell cycle (reviewed by Ref. [14]). Recently, malignant
glioma cells infected with an RNA virus, alphavirus M1, were
shown to accumulate in S phase by down-regulating p21 protein
[15]. The interaction between SINV replication and the host cell
cycle has not been studied in detail, particularly in the context of
oncolysis.
In this study, we analyzed the dynamics of cell cycle phases of
HeLa and Vero cells infected with SINV in order to elucidate the
interaction between SINV replication and the host cell cycle.2. Materials and methods
2.1. Cell lines
HeLa cells were obtained from the American Type Culture
Collection (ATCC; Rockvile, MD). Vero cells were laboratory stock.
Cells were grown in Dulbecco's modiﬁed Eagle's medium (DMEM;
Sigma) with 10% fetal bovine serum (FBS) at 37 C in 5% CO2.e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
R. Yi et al. / Biochemical and Biophysical Research Communications 462 (2015) 426e432 4272.2. Viral stocks and construction of recombinant virus
We used the laboratory stock of the AR339 strain of SINV. The
plasmid pTR339-GFP-2A was kindly provided by Dr. Hans W.
Heidner (University of Texas, San Antonio, TX; [16]). The BFP gene is
substituted for the GFP gene in the pTR339-GFP-2A plasmid, to
yield pTR339-BFP-2A.2.3. RNA transcription
For in vitro transcription, pTR339-BFP-2A plasmid was puriﬁed
using the HiSpeed Plasmid Midi Kit (Qiagen), linearized with XhoI
(Biolab), and transcribed in vitro with the RiboMAX™ Large-Scale
RNA production system-SP6 kit (Promega).2.4. Imaging of cultured cells
Cells were grown on a 35-mmdish in DMEMwith 10% FBS. After
virus infection and incubation at 37 C in 5% CO2 for 1.5 h, cells were
subjected to long-term, time-lapse imaging using a computer-
assisted ﬂuorescence microscope (Olympus, FV10i) at 37 C in 5%
CO2. Images were recorded every 30 min. Three ﬁlter cubes were
chosen for ﬂuorescence imaging: mKusabira-orange (excitation
wavelength 548 nm, emissionwavelength 559 nm) to observe Fucci
orange, Azami Green (excitation wavelength 493 nm, emission
wavelength 505 nm) to observe Fucci green, and Blue-NarrowFig. 1. The effect of SINV infection on cell cycle progression. HeLa or Vero cells were infected
(hpi). (A) FACS analysis of mock-infected (Mock) and SINV-infected (SIN) HeLa cells at 2, 4, 7,
proportions of mock- and SINV-infected cells in G0/G1, S, and G2/M phases. (C) FACS analy
Percentages of cells in G0/G1, S, and G2/M are shown. (D) The time course of proportions of m
mean of three independent experiments. Error bars indicate standard error.(excitation wavelength at 405 nm, emission wavelength
420e460 nm) to observe BFP. We used Fluoview version 3.1
(Olympus) for image acquisition and analysis.2.5. Western blotting
Equal volumes of extracted protein were loaded onto SDS-
polyacrylamide gels (Atto Corporation), transferred onto PVDF
membranes (Trans-Blot Turbo™ Transfer Pack, BIO-RAD), and
analyzed with antibodies.2.6. Cell cycle analysis
Cells were collected andwashed twicewith PBS. Next, cells were
treated with reagents from the CycleTEST™ PLUS DNA Reagent Kit
(Becton Dickinson and Company) and analyzed on a BDAccuri™ C6
Flow Cytometer (Becton Dickinson and Company) equipped with
FACScan's ﬂuorescence 2 (FL2) detector. The collected data was
analyzed using FlowJo 7.6.5 (TreeStar Company).2.7. Statistical analysis
All values were expressed as mean ± SD. Statistical analyses
were performed using the software Statcel2, version 2 (OMS, Tokyo,
Japan). Values of P < 0.05 were considered statistically signiﬁcant.with 1 MOI of SINV and subjected to FACS analysis at the indicated hour post-infection
and 15 hpi. Percentages of cells in G0/G1, S, and G2/M are shown. (B) The time course of
sis of mock-infected (Mock) and SINV-infected (SIN) Vero cells at 2, 4, 7, and 14 hpi.
ock- and SINV-infected Vero cells in G0/G1, S, and G2/M phases. Data presented are the
Fig. 1. (continued).
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3.1. Effects of SINV infection on cell cycle progression in HeLa and
Vero cells
To investigate the impact of SINV infection on cell cycle pro-
gression, we used ﬂuorescence-activated cell sorting (FACS) anal-
ysis to assess the effect of SINV infection on the distribution of
HeLa and Vero cells in each phase of the cell cycle. Cells infected
with 1 MOI of SINV or mock-infected were subjected to FACS
analysis at 2, 4, 7, and 15 h post-infection (hpi) in HeLa cells and at
2, 4, 7, and 14 hpi in Vero cells. SINV infection signiﬁcantly altered
the cell cycle proﬁle in HeLa cells (primary data are shown in
Fig. 1A, and the time course of the proportion of cells in G0/G1, S,
and G2/M phases are shown in Fig. 1B). The proportion of HeLa
cells in S phase increased and proportions of HeLa cells in G0/G1
and G2/M decreased by 4 hpi, suggesting that SINV infection might
simultaneously promote cell entry into S phase and prevent exit
from S phase (Fig. 1A). The proportions of SINV-infected cells in
each stage of the cell cycle approached the respective proportions
of mock-infected cells by 7 hpi (Fig. 1B). Then, the proportions of
infected cells in G0/G1 and S phases increased and decreased,
respectively, suggesting that cell cycle progression from G1 to S
phase was blocked and that cells accumulated in G0/G1 at the later
stage of infection.
In contrast, SINV infection caused little effect on the cell cycle
progression of Vero cells during the early stage of infection (Fig.1C).
However, at the later stage of infection (by 14 hpi), the proportion
of infected cells in S phase had increased and the proportions of
infected cells in G0/G1 and G2/M had decreased (Fig. 1D).3.2. Effects of SINV infection on the expression of cell cycle
regulators in HeLa cells
To characterize the molecular basis for the effects of SINV
infection on the cell cycle in HeLa cells, we examined the levels of
key cell cycle regulatory proteins. These cellular proteins were
collected from mock- and SINV-infected HeLa cells at 2, 4, 7, and
15 hpi, and protein levels were measured using Western blotting
(Fig. 2).
Because the cyclin D/CDK4 (CDK6) complex is active during
early G1 and regulates the progression of G1, we examined the
expression of these proteins and their regulators in infected HeLa
cells. Although cyclin D1 expression was not affected by SINV
infection by 7 hpi, cyclin-dependent kinases CDK4 and CDK6 were
both expressed at higher levels in SINV-infected cells at 4 and 7 hpi
(Fig. 2A). The elevated expression of CDK4 and CDK6 may account
for the acceleration of G1 progression, followed by the decreased
proportion of G0/G1 cells observed by FACS analysis in HeLa cells at
4 hpi.
During late G1, the activated cyclin E/CDK2 complex promotes
the G1/S transition by phosphorylating pRB [17]. Cyclin E, the
overexpression of which shortens the duration of G1 phase inde-
pendently of pRB [18e20], increased signiﬁcantly at 4 and 7 hpi in
SINV-infected HeLa cells (Fig. 2B). The expression pattern of cyclin E
in SINV-infected cells was similar to the expression patterns of
CDK4 and CDK6. Total CDK2 expression in SINV-infected cells was
not affected by the infection (Fig. 2B). Because CDK2 activity is
regulated by phosphorylation at Thr160 and activated by Cdc25A-
mediated dephosphorylation of Thr14 and Tyr15 [21], we exam-
ined the expression of p-CDK2 (Thr160) and Cdc25A. Although p-
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expressed at a higher level in SINV-infected cells at 7 hpi (Fig. 2B).
Meanwhile, the expression of p21, which binds to and inhibits the
cyclin E/CDK2 complex [22,23], was decreased signiﬁcantly in
SINV-infected cells at 4 hpi (Fig. 2B). Taken together, the up-
regulation of cyclin E and Cdc25A and down-regulation of p21
were thought to shorten G1 and promote the G1/S transition, in
cooperation with CDK4/6-promoted G1 progression.
Cyclin A associates with CDK2 and regulates the progression of S
phase [24]. We observed suppressed cyclin A expression in SINV-
infected cells at 4 hpi (Fig. 2C). This might cause retardation of S
phase, and was consistent with the decrease of cells in G2/M phase
and the increase of cells in S phase in SINV-infected HeLa cells
observed by FACS analysis.
Entry into M phase is signaled by the accumulation of cyclin B-
cdc2, and the activation of cdc2 requires dephosphorylation at
Tyr15 and Thr14 [25]. Therefore, we measured the levels of cyclin
B1 and phosphorylated p-cdc2 (Tyr15) protein in SINV-infected
HeLa cells. Cyclin B1 expression was suppressed in SINV-infected
cells (Fig. 2C), indicating that SINV infection might block the cell
cycle transition through the G2/M checkpoint. Failure to pass the
DNA replication checkpoint results in the inhibition of cdc25C ac-
tivity, in turn leading to inhibition of the dephosphorylation of cdc2
[26]. Therefore, higher levels of p-cdc2 protein (the inactive form of
the protein) in SINV-infected cells at 4 hpi (Fig. 2C) agreed with theFig. 2. Western blots of mock- and SINV-infected HeLa cells assess the expression of cell cyc
cells at 2, 4, 7, and 15 h post-infection (hpi) were subjected toWestern blotting. (A) Western b
transition regulators cyclin E, CDK2, p-CDK2 (Thr160), Cdc25A, and p21. The bars indicate
transition regulators cyclin B1 and p-cdc2. b-actin was an internal marker for equivalent ptemporal accumulation of cells in S phase at 4 hpi observed by FACS
analysis.
At 15 hpi, the expression of cyclin D1 in infected cells was un-
detectable, and both CDK4 and CDK6 were expressed at low levels
(Fig. 2A). The suppression of cyclin D1, CDK4, and CDK6 at 15 hpi
suggested that the progression of G1 phase should be blocked
during the later stage of infection. The expression of cyclin E, p-
CDK2, and Cdc25A in infected cells also decreased at 15 hpi
(Fig. 2B), suggesting that the G1/S transition should also be blocked.
The suppressed expression of these proteins at 15 hpi was consis-
tent with the increased proportion of SINV-infected HeLa cells in G1
phase at 15 hpi observed by FACS analysis. By 15 hpi, the expression
of cyclin A, which regulates the progression of S phase, had
decreased in infected cells (Fig. 2C), suggesting that cells in S phase
might be arrested during the later stage of infection.3.3. Viral replication and cell cycle phases in HeLa-Fucci and Vero-
Fucci cells
The differences in the cell cycle progression of HeLa and Vero
cells after SINV infection might reﬂect differences between cancer
cells and non-cancerous cells regarding the status of the cell cycle.
Such differences might cause variations in viral replication
depending on cell cycle phase. To test this hypothesis, wele regulator proteins. Total protein from SINV-infected (SIN) and mock-infected (Mock)
lots of the G1 phase regulators cyclin D1, CDK4, and CDK6. (B) Western blots of the G1/S
the positions of cyclin E and Cdc25A. (C) Western blots of cyclin A, as well as G2/M
rotein loading.
Table 1
HeLa-Fucci and Vero-Fucci cells infected with TR339-BFP-2A.
Cells Cell cycle phase
HeLa-Fucci Vero-Fucci
G1 S/G2/M Total G1 S/G2/M Total
Total including uninfected at 2 hpi (%) 237(40) 362(60) 599 186(51) 178(49) 364
Infected at 2 hpi (%) 89(41) 128(59) 217 109(57) 81(43) 190
Expressing BFP
Number of cells (%) 148(52) 134(48) 282 122(51) 116(49) 238
Number of clones (%) 89(41) 128(59) 217 90(47) 100(53) 190
Apoptosis (%) 150(53) 133(47) 283 128(53) 113(47) 241
Fig. 3. The replication of BFP-expressing SINV, TR339-BFP-2A, in HeLa-Fucci and Vero-Fucci cells. Fucci labels nuclei orange during G1 phase and green during S/G2/M phases. After
infection with BFP-expressing SINV, TR339-BFP-2A, images of HeLa-Fucci and Vero-Fucci cells were obtained at 30-min intervals with a computer-assisted ﬂuorescence microscope
(Olympus, FV10i). Co-expression of blue ﬂuorescent protein (BFP) with structural proteins from TR339-BFP-2A was observed in the cytoplasm. The lineage of each BFP-expressing
cell was traced, and the cell cycle phase during which TR339-BFP-2A infection took place was determined. Arrows indicate cells that were infected during G1 and expressed BFP
during G1 (A) or S/G2 (B), cells that were infected during S/G2 and expressed BFP during S/G2 (C), or G1 phase after cell division (D). The images shown were recorded at 2 h post-
infection (2 hpi) and at the time of BFP expression (BFPþ).
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Table 2
Kinetics of the SINV replication in HeLa-Fucci and Vero-Fucci cells, and the cell cycle phases at infection.
Length of interval Cell cycle phase at infection
HeLa-Fucci infected during Vero-Fucci infected during
G1 S/G2/M Mean G0/G1 S/G2/M Mean
BFP expression (h) 9.3*
(±2.0)
10.4*
(±2.7)
10.0
(±2.6)
8.9y
(±3.1)
10.2y
(±3.4)
9.6
(±3.3)
Apoptosis (h) 13.1**
(±2.4)
14.3**
(±3.0)
13.8
(±2.9)
13.7yy
(±3.5)
14.7yy
(±3.3)
14.3
(±3.4)
Between BFP expression and apoptosis (h) 3.8
(±1.3)
3.9
(±1.4)
3.8
(±1.4)
4.9
(±1.7)
4.5
(±1.4)
4.7
(±1.5)
Standard deviations are in parentheses.
*P < 0.0001; **P < 0.005; yP < 0.005; yyP < 0.01 (all according to the ManneWhitney U-test).
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cator, Fucci, in HeLa and Vero cells.
We established HeLa-Fucci and Vero-Fucci cell lines by intro-
ducing pFucci-G1 orange and pFucci-S/G2/M Green-hyg (Amal-
gaam) successively into Vero and HeLa cells. In both cell lines,
Fucci effectively labeled individual nuclei in G1 phase as orange
and those in S/G2/M phases as green [27]. To label viral replication,
HeLa-Fucci and Vero-Fucci were infected with TR339-BFP-2A,
which contains the BFP gene between capsid and E3, and co-
expresses BFP with viral structural proteins. After viral infection
with TR339-BFP-2A, HeLa-Fucci and Vero-Fucci cells were imaged
using a computer-assisted ﬂuorescence microscope (Olympus,
FV10i). Images were recorded every 30 min until most cells
exhibited apoptosis.
The serially collected images of 217 infected HeLa-Fucci and 190
infected Vero-Fucci cells were traced and analyzed regarding cell
cycle phases, the timing of the appearance of BFP ﬂuorescence, and
the time interval between BFP appearance and apoptosis. As shown
in Table 1, the proportions of infected HeLa cells in G1 and S/G2/M
phase at 2 hpi were 41% and 59%, respectively; these were equal
with the proportions of total cells in G1 (40%) and S/G2/M phase
(60%), respectively. The proportions of infected Vero cells in G1
(57%) and S/G2/M phases (43%) also exhibited no obvious difference
from the proportions of total cells in G1 (51%) and S/G2/M phase
(49%), respectively.Fig. 4. Cell-cycle kinetics of HeLa-Fucci (A) and Vero-Fucci (B) cells infected with TR339-BFP-
G2. The lineage of each BFP-expressing cell was traced, and the cell cycle phase during whic
traced cells are shown. The intervals between infection and BFP expression are shown at the r
between HeLa-Fucci and Vero-Fucci cells (x, P < 0.05, chi-square test). *P < 0.005; **P < 0.0The proportions of BFP-expressing cells in respective cell cycle
phases were as follows: HeLa-Fucci, 52% in G1 and 48% in S/G2/M;
Vero-Fucci, 51% in G1 and 49% in S/G2/M. When the BFP-expressing
cells were traced back to 2 hpi, the respective proportions of clones
in cell cycle phases G1 and S/G2/Mwere 41% and 59% for HeLa-Fucci
and 47% and 53% for Vero-Fucci cells. Almost all cells underwent
apoptosis during the same cell cycle phase at which BFP was
expressed.
Cells infected during G1 phase expressed BFP during G1 or S/G2
phase, and cells infected during S/G2 phase expressed BFP during S/
G2 or after exiting M phase (Fig. 3AeD). The mean interval between
adsorption and BFP expression in cells infected during G1 was 9.3 h
for HeLa cells and 8.9 h for Vero cells. The corresponding intervals
were signiﬁcantly longer for HeLa-Fucci and Vero-Fucci cells
infected during S/G2/M (10.4 h and 10.2 h, respectively, Man-
neWhitney U-test; P < 0.05) (Table 2). Apoptosis was always
observed a few hours after the appearance of BFP (Table 2). The
mean intervals between BFP appearance and apoptosis differed
between cell lines (HeLa-Fucci: 3.8 h; Vero-Fucci: 4.7 h), but did not
differ signiﬁcantly between cells infected during G1 phase and
those infected during S/G2/M phase (Table 2). During the interval
between BFP appearance and apoptosis, the color of Fucci changed
only in a few cells that expressed BFP during M phase, indicating
that most cells underwent cell cycle arrest once the virus started to
replicate.2A during G1 and S/G2 phase. Nuclei were labeled orange during G1 and green during S/
h TR339-BFP-2A infection took place was determined (G1 or S/G2). The numbers of the
ight (BFPþ). The distributions of BFP-expressing cells in G1 and S/G2 differed signiﬁcantly
001; yP < 0.005; yyP < 0.00001 (all according to the ManneWhitney U-test).
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G1 expressed BFP after entering S/G2; in contrast, 31% of cells
infected during G1 phase expressed BFP during G1 phase (Fig. 4A).
The preference for viral replication during S/G2 phase in HeLa-Fucci
cells was consistent with the promotion of the G1/S phase transi-
tion by infection. Fewer Vero-Fucci cells infected during G1 (52%)
than HeLa-Fucci cells infected during G1 expressed BFP during S/G2
(chi-square test; P < 0.05) (Fig. 4B). Quite a few cells expressed BFP
during M phase in both HeLa-Fucci and Vero-Fucci cells. The mean
intervals between adsorption and BFP expressionwere signiﬁcantly
longer for cells that were infected during S/G2 phase and pro-
gressed through M phase than for cells that did not progress
through M phase (ManneWhitney U-test; P < 0.05), suggesting
that viral proliferation might be suspended during M phase.4. Discussion
In the present study, we observed that SIN infection altered the
cell cycle progression in HeLa and Vero cells; however, these cell
lines' responses to SIN infection differed during the early stage of
infection. SIN infection caused HeLa cells to accumulate in S phase,
with the proportion of cells in G1 and G2/M phases decreasing by
4 hpi. Changes in the expression of cell cycle regulators during the
early stage of SIN infection were considered to contribute to the
promotion of the G1/S transition and cell cycle retardation in S
phase.
Using HeLa-Fucci cells infected with TR339-BFP-2A, we traced
individual cells from infection to apoptosis. We conﬁrmed that SIN,
which infected HeLa cells but not Vero cells during G1, preferred to
proliferate during S/G2, and the average length of time for viral
replication was shorter in cells infected during G1 than in cells
infected during S/G2/M phase. Because cells that expressed BFP
during M phase were rare in Fucci expression experiments, viral
proliferation appeared to be suspended during M phase. The sus-
pension of viral proliferation in M phase might explain why the
cells that were infected during S/G2 and progressed throughM took
longer to express BFP.
Given that 80e90% of cellular RNA and protein synthesis is
inhibited a few hours after infection by SIN [28,29], it is noteworthy
if the inhibition of RNA and protein synthesis is able to affect the
expression of cell cycle regulators and cell cycle progression. In this
study, after HeLa cells were infected with SIN, the expression of
most cell cycle regulators exhibited no decrease at 7 hpi, but had
decreased or disappeared by 15 hpi. Cell-cycle analyses between 7
and 15 hpi indicated that cell cycle progression still took place in
infected HeLa cells. In experiments using Fucci-expressing cells,
more than one-half of infected HeLa-Fucci and Vero-Fucci cells
expressed BFP in cell cycle phases other than the phases during
which infection occurred.
In conclusion, SINV infection can affect the expression of cell
cycle regulators and drive cancer cells to accumulate in S phase.Conﬂict of interest
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